Gray Cameron 4
4 · Cue Biopharma, Inc. · Filed Jan 3, 2019
Insider Transaction Report
Form 4
Gray Cameron
Director
Transactions
- Award
Stock Option (right to buy)
2019-01-02+8,000→ 8,000 totalExercise: $5.16From: 2020-01-02Exp: 2026-01-02→ Common Stock (8,000 underlying)